Carter; Malcolm Clive
Patent Applications and Registrations
Patent applications and USPTO patent grants for Carter; Malcolm Clive.The latest application filed is for "bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors".
- Carter; Malcolm Clive - Stevenage GB
- Carter; Malcolm Clive - Ware N/A GB
- Carter; Malcolm Clive - London GB
- Carter; Malcolm Clive - Hertfordshire GB
- Carter; Malcolm Clive - Herts GB
| Patent | Date |
|---|---|
| Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20160339027 - Carter; Malcolm Clive ; et al. | 2016-11-24 |
| Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20160051551 - Carter; Malcolm Clive ; et al. | 2016-02-25 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 9,199,973 - Carter , et al. December 1, 2 | 2015-12-01 |
| Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20150065527 - Carter; Malcolm Clive ; et al. | 2015-03-05 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 8,912,205 - Carter , et al. December 16, 2 | 2014-12-16 |
| Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20130310562 - Carter; Malcolm Clive ; et al. | 2013-11-21 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 8,513,262 - Carter , et al. August 20, 2 | 2013-08-20 |
| Biphenyl derivatives and their use in treating hepatitis C Grant 8,008,303 - Wheelhouse , et al. August 30, 2 | 2011-08-30 |
| Pyrimidine Derivatives App 20100267755 - Bravi; Gianpaolo ; et al. | 2010-10-21 |
| Novel Compounds - 644 App 20100215618 - Carter; Malcolm Clive ; et al. | 2010-08-26 |
| Biphenyl Derivatives and Their Use in Treating Hepatitis C App 20080255105 - Wheelhouse; Christopher James ; et al. | 2008-10-16 |
| Heterocyclic Compounds App 20070238875 - CARTER; Malcolm Clive ; et al. | 2007-10-11 |
| Heterocyclic compounds Grant 7,109,333 - Carter , et al. September 19, 2 | 2006-09-19 |
| Substituted pyrimidines as selective cyclooxygenase-2 inhibitors Grant 7,084,148 - Carter , et al. August 1, 2 | 2006-08-01 |
| Substituted pyrimidines as selective cyclooxygenase-2 inhibitors App 20050282845 - Carter, Malcolm Clive ; et al. | 2005-12-22 |
| Heterocyclic compounds App 20050130996 - Carter, Malcolm Clive ; et al. | 2005-06-16 |
| Heterocyclic compounds Grant 6,828,320 - Cockerill , et al. December 7, 2 | 2004-12-07 |
| Pyrimidine derivatives as selective inhibitors of COX-2 Grant 6,780,870 - Carter , et al. August 24, 2 | 2004-08-24 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 6,727,256 - Carter , et al. April 27, 2 | 2004-04-27 |
| Protein tyrosine kinase inhibitors Grant 6,723,726 - Cockerill , et al. April 20, 2 | 2004-04-20 |
| Heterocyclic compounds Grant 6,713,485 - Carter , et al. March 30, 2 | 2004-03-30 |
| Heterocyclic compounds App 20030176451 - Carter, Malcolm Clive ; et al. | 2003-09-18 |
| Pyrmidine derivatives as selective inhibitors of cox-2 App 20030109538 - Carter, Malcolm Clive ; et al. | 2003-06-12 |
| Heterocyclic compounds App 20020147214 - Cockerill, George Stuart ; et al. | 2002-10-10 |
| Heterocyclic compounds App 20020147205 - Carter, Malcolm Clive ; et al. | 2002-10-10 |
| Fused heterocyclic compounds as protein tyrosine kinase inhibitors Grant 6,391,874 - Cockerill , et al. | 2002-05-21 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 6,207,669 - Cockerill , et al. March 27, 2 | 2001-03-27 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 6,174,889 - Cockerill , et al. January 16, 2 | 2001-01-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 